| ID | PMID | SEQUENCE | NAME | LENGTH | ACTIVITY |
| 1102 | 18617323 | RAGLQFPVGRLLRRLLRRLLR | Buforin IIb | 21 | IC50=12.6 µg/ml |
| 1712 | None | FLGWLFKWAKK | Gaegurin peptides SEQID NO: 1 | 11 | IC50 = 24.76 mM |
| 1718 | None | FLKWLFKWAKK | Gaegurin peptides SEQID NO: 2 | 11 | IC50 = 12.55 mM |
| 1724 | None | FLGWLFKWAWK | Gaegurin peptides SEQID NO: 3 | 11 | IC50 = 22.06 mM |
| 1730 | None | FLWWLFKWAWK | Gaegurin peptides SEQID NO: 4 | 11 | IC50 = 14.58 mM |
| 1748 | None | FLGWLFKWAKK | Gaegurin peptides SEQID NO: 1 | 11 | IC50 = 24.76 mM |
| 1756 | None | FLKWLFKWAKK | Gaegurin peptides SEQID NO: 2 | 11 | IC50 = 12.55 mM |
| 1764 | None | FLGWLFKWAWK | Gaegurin peptides SEQID NO: 3 | 11 | IC50 = 22.06 mM |
| 1772 | None | FLWWLFKWAWK | Gaegurin peptides SEQID NO: 4 | 11 | IC50 = 14.58 mM |
| 3158 | 23301519 | WRWRWRWRW | Cyclic [W(RW)4 ]-Dox | 9 | 51-74% inhibition of cell proliferation at 1 µM |
| 3162 | 23301519 | RWRWRWRW | linear (RW)4-Dox | 8 | 28-34% antiproliferative activity at 1 µM |
| 3232 | 22644847 | FLGWLFKWAWK | GA-W3 | 11 | IC50 =22.06 µM |
| 3239 | 22644847 | FLWWLFKWAWK | GA-W4 | 11 | IC50 =14.58 µM |
| 3246 | 22644847 | FLGWLFKWAKK | GA-K3 | 11 | IC50 |
| 3253 | 22644847 | FLKWLFKWAKK | GA-K4 | 11 | IC50 =12.55 µM |
| 3733 | 22644847 | FLGWLFKWAWK | GA-W3 | 11 | IC50= 22.06 µM |
| 3740 | 22644847 | FLWWLFKWAWK | GA-W4 | 11 | IC50= 14.58 µM |
| 3747 | 22644847 | FLKWLFKWAKK | GA-K3 | 11 | IC50= 24.76 µM |
| 3754 | 22644847 | FLKWLFKWAKK | GA-K4 | 11 | IC50= 12.55 µM |